Announced Tue, 28 Jul · 10:49 IST
Board Meeting on Aug 6 2026 to Consider Q1 FY27 Results
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.7%1-day move
₹55.50
prior close
₹53.80
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
—+2.0+2.0+0.0-2.7-3.2-3.4+2.7-1.0-2.3+0.0+6.8——
Up moveDown movePending
AI summary
Krebs Biochemicals & Industries has informed BSE that the Board of Directors will meet on Thursday, August 6, 2026 to consider and adopt the unaudited financial results for Q1 ended June 30, 2026. The company had previously announced the closure of the insider trading window from June 30, 2026 until 48 hours after the declaration of results, in line with SEBI insider trading norms.
Likely market impact
Q1 FY27 earnings announcement could drive short-term price movement. Insider trading window remains closed, limiting insider activity till results are out.